Order Plinest®One for Clinics

Plinest®One is a sterile polynucleotide injectable for intradermal use in professional aesthetic practice. Licensed clinics, med spas, and healthcare professionals can order Plinest One for clinic protocols that require 4 mL vials supplied in a five-vial carton. Each vial contains polydeoxyribonucleotide at 2 mg/mL, supporting treatment-room planning, lot documentation, and inventory allocation for skin-quality workflows.

Ready to order? Choose your quantity above, or call 1-800-630-9757 to talk to our customer service team.

Plinest®One 4 mL Vials, Strength, and Clinic Ordering

Plinest®One is supplied as 4 mL x 5 sterile vials. The concentration is 2 mg/mL polydeoxyribonucleotide, often abbreviated as PDRN. This format helps practices allocate a carton across scheduled sessions, treatment rooms, or practitioners while maintaining a clear record of lot and expiry information.

Current prices and quantity breaks are shown on this page, and licensed clinics can order as a guest or with an account. Pricing may vary by purchasing status and order size, so teams with recurring PN use should set reorder points around actual session volume rather than estimated demand alone.

Order records should align with your clinic’s internal purchasing controls. Staff can match vial use to appointment blocks, document the lot number in the clinical record, and reconcile remaining sealed stock at the end of the day. For broader PN and injectable skin-quality inventory, the skin boosters category can help teams review adjacent clinic-use products without changing the core Plinest®One protocol.

What Plinest®One Is Used For in Aesthetic Practice

Plinest®One is used in professional skin-quality protocols where the goal is dermal conditioning, hydration balance, elasticity support, and texture-focused rejuvenation. It is not a volumizing dermal filler. Clinics typically position polynucleotide treatments as regenerative or biostimulatory skinbooster sessions, with technique, anatomical site selection, and treatment cadence determined by the licensed professional.

Polynucleotides are purified DNA fragments used in aesthetic medicine to support native repair pathways. In practice, this class is commonly selected for micro-deposit intradermal techniques on areas where subtle quality improvements are prioritized. Common professional-use areas may include the face, neck, hands, and other sites selected under clinic protocol.

Because Plinest®One does not provide structural volume in the way hyaluronic acid fillers do, it can sit alongside device-based rejuvenation, microneedling, mesotherapy, and filler programs. Clinics often separate goals by session: filler for contour or support, energy devices for tightening or resurfacing, and PN injections for dermal conditioning. For clinical background on PN-based protocols, the article on dermal repair with Plinest injections provides additional practice context.

Active Ingredient and Mechanism

The active ingredient is polydeoxyribonucleotide at 2 mg/mL in a sterile aqueous vehicle. PDRN is a purified biological derivative used in professional aesthetic care. The preparation belongs to the broader polynucleotide category, a class selected for tissue-quality programs rather than immediate lifting or filling effects.

In clinical discussions, PDRN is often described as supporting the extracellular environment and cellular repair signaling. For purchasing and protocol planning, the practical distinction is straightforward: Plinest®One is a PN injectable intended for intradermal administration by trained professionals. It should be used according to the manufacturer’s instructions and your clinic’s clinical governance standards.

Clinics may use Plinest®One as a stand-alone PN session or as one part of a multimodal program. If your practice runs mesotherapy pathways, the mesotherapy category offers related professional-use context for injectable skin-rejuvenation workflows. Product choice should remain linked to patient assessment, clinician training, and documented consent.

Professional Applications and Treatment-Room Fit

Plinest®One can be integrated into intradermal micro-deposit protocols for texture-focused programs across selected treatment areas. Clinics may schedule it around microneedling, energy-based rejuvenation, platelet-rich plasma workflows, or hyaluronic acid skinbooster appointments when this sequencing fits local policy. Treatment timing should reflect skin condition, device recovery windows, and clinician preference.

The 4 mL vial format supports multi-spot professional techniques. Teams can prepare the treatment room with the selected syringes, needles, antiseptic, sharps handling, and post-procedure documentation before opening sterile stock. Once a vial is opened, handling should follow the manufacturer’s instructions and your clinic’s sterile-use policy.

Under-eye use is a common question in PN discussions, but product and area selection should be conservative and clinician-led. Plinest®One may be used in delicate areas only when the treating professional considers it appropriate for the patient and technique. Practices with periocular protocols may also review Plinest®Eye for area-specific planning within the Plinest range.

Key Features for Clinic Inventory

• Polynucleotide platform prepared for professional intradermal administration.
• 4 mL x 5 vial carton for scheduled treatment-room use.
• 2 mg/mL polydeoxyribonucleotide concentration.
• Sterile vials intended for trained healthcare professionals.
• Carton and vial labels support lot, expiry, and stock reconciliation.
• Useful for skin-quality protocols rather than volumizing filler correction.
• Compatible with broader aesthetic workflows when selected by the treating clinician.

Quick tip: Assign cartons by room, practitioner, or session block to simplify lot tracking and end-of-day reconciliation.

Storage, Handling, and Documentation

Follow the storage instructions printed on the carton and vial. Keep stock in its original packaging until use, protect sealed units from unnecessary handling, and separate expired or damaged items from active clinical inventory. If your clinic uses centralized stock control, record receipt dates, quantities, lot numbers, and expiry dates during intake.

Professional documentation should connect each administered vial to the patient record, anatomical site, session date, and treating clinician. This supports continuity across a series and helps maintain audit-ready records. For larger clinics, barcode scanning or a standard manual log can reduce discrepancies between front-desk scheduling, treatment-room use, and purchasing records.

Orders are supported with temperature-controlled handling when required and tracked US delivery. Delivery planning should account for staff availability, receiving procedures, and storage transfer on arrival. Avoid scheduling product-dependent sessions before your team has received and inspected the relevant stock.

Benefits in Practice

Plinest®One supports predictable clinic workflows because the carton contains five 4 mL vials in a consistent presentation. This can reduce mid-day stock changes and help teams allocate units to multi-area plans. Clear labeling also supports post-use reconciliation, especially in practices running multiple injectable rooms.

From a clinical-program perspective, the product helps separate treatment goals. PN sessions can be positioned for skin quality, while fillers can be reserved for contour, projection, or structural support. This separation may simplify consultation notes, consent language, and follow-up assessment because each session has a clearer treatment objective.

Practices that combine regenerative aesthetics with device or biologic procedures may also want to review platelet-rich plasma therapy for skin regeneration. That content can help teams compare how PN and PRP concepts are typically framed in professional rejuvenation programs.

Plinest®One Compared With Other Plinest Products

Plinest®One sits within a wider Mastelli Plinest portfolio. The right product depends on treatment area, skin quality goals, clinician technique, and the protocol used by your practice. Avoid choosing solely by name similarity; concentration, presentation, and intended use may differ across products.

Clinics comparing Plinest One vs Plinest often look at how each preparation fits their session design. Plinest® may be reviewed for broader PN complex planning, while Plinest®Fast may suit practices evaluating another product in the same brand family. For hair-focused protocols, Plinest®Hair is the more relevant related item to assess.

For a wider category view, practices can also consult the editorial discussion of mesotherapy injections in non-surgical rejuvenation. Use related products and clinical articles as decision support, not as substitutes for manufacturer instructions, training, or patient-specific assessment.

Safety, Contraindications, and Professional Precautions

Plinest®One should be administered only by trained, licensed professionals using appropriate aseptic technique. As with injectable aesthetic products, local injection-site reactions may occur. These can include redness, swelling, tenderness, bruising, or temporary discomfort. Clinics should discuss expected post-treatment responses and aftercare instructions through their usual consent process.

Patient suitability should be assessed before treatment. Aesthetic injectable protocols commonly require review of medical history, allergies, active skin infection, inflammatory skin conditions at the treatment site, immune status, pregnancy or breastfeeding considerations, anticoagulant use, and recent procedures. The treating professional should decide whether to proceed, delay, modify technique, or choose another modality.

Serious adverse reactions are uncommon but require prompt clinical attention. Clinics should have procedures for managing hypersensitivity, unexpected swelling, infection concerns, vasovagal reactions, and post-procedure complications. Maintain emergency supplies and escalation pathways consistent with your practice setting and professional requirements.

PN products are not substitutes for prescription dermatologic care when a patient has an active disease process. They are also not volumizing fillers and should not be represented as immediate contouring products. Accurate consultation language helps align expectations and reduces the risk of misunderstanding between skin-quality improvement and structural correction.

Ordering, Account Access, and Replenishment

Plinest®One is available for licensed medical organizations and verified healthcare professionals. Credential review helps ensure that professional-use products are supplied to appropriate clinical settings.

For recurring use, set par levels based on booked PN sessions, typical vial use, and the clinic’s reorder lead time. Larger practices may assign ordering permissions to specific staff, consolidate monthly purchasing, and use itemized records for internal reconciliation. During high-demand periods, our customer service team can help align order quantities with verified clinic demand.

When evaluating substitutes, confirm any change with the clinical team before scheduling patients. Equivalent category placement does not always mean identical handling, technique, or treatment objective. Documentation should clearly show which product was used and why a substitution was approved.

Authoritative Sources

• Mastelli aesthetic medicine product information

This content is for informational purposes only and is not a substitute for professional medical advice.